Strategic Advocates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Strategic Advocates's MRK Position: Q2 2026 in Review
Strategic Advocates opened a new position in Merck (MRK) in Q2 2026: 16 shares worth $2.06K. The stake represents 0.01% of the portfolio and ranks #206 among its holdings. This is a return to the name: Strategic Advocates previously reported a position in MRK as recently as Q4 2025.
Strategic Advocates first reported a position in MRK in Q1 2024 and has held it in 4 quarters since. The position peaked at $230K in Q1 2024. 3,837 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Strategic Advocates held 16 shares of Merck worth $2.06K as of Q2 2026.
- Merck was a new Strategic Advocates position in Q2 2026.
- Merck made up 0.01% of Strategic Advocates's portfolio in Q2 2026, its #206 holding.
- Strategic Advocates first reported a position in Merck in Q1 2024 and has held it in 4 quarters since.
- Strategic Advocates's Merck position peaked at $230K in Q1 2024.
- 3,837 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Strategic Advocates's 13F filing for Q2 2026, filed 13 Aug 2026.